Controlled preparation and antitumor efficacy of vitamin e TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel

International Journal of Pharmaceutics

Volumn 446, Issue 1-2, 2013, Pages 24-33

  Wang, Guoying ^a,b   Yu, Bo ^c   Wu, Yuequn ^b   Huang, Baolin ^a,b   Yuan, Yuan ^a,b   Liu, Chang Sheng ^a,b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b East China University of Science and Technology   (China)

^c Biotech (Hangzhou) CoLtd   (China)

Author keywords

Antitumor efficacy; Controllable preparation; Drug delivery; Paclitaxel; TPGS functionalized PLGA nanoparticles

Indexed keywords

ALPHA TOCOPHEROL; NANOPARTICLE; PACLITAXEL; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG STABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MOLECULAR WEIGHT; MOUSE; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CHEMICAL PRECIPITATION; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; HUMANS; LACTIC ACID; LUNG NEOPLASMS; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; TREATMENT OUTCOME; TUMOR BURDEN; VITAMIN E; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874398730     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.02.004     Document Type: Article

References (38)

1. N. Akhtar, A. Ahad, R.K. Khar, M. Jaggi, M. Aqil, Z. Iqbal, F.J. Ahmad, and S. Talegaonkar The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review Expert Opin. Ther. Pat. 21 2011 561 576
2. K. Bogman, F. Erne-brand, J. Alsenz, and J. Drewe The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins J. Pharm. Sci. 92 2003 1250 1261
3. P. Chambon, L. Chen, S. Furzeland, D. Atkins, J.V.M. Weaver, and D.J. Adams Poly(N-isopropylacrylamide) branched polymer nanoparticles Polym. Chem. 2 2011 941 949
4. H.B. Chen, Y. Zheng, G. Tian, Y. Tian, X.W. Zeng, G. Liu, K.X. Liu, L. Li, Z. Li, L. Mei, and L.Q. Huang Oral delivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapy Nanoscale Res. Lett. 6 2011 2 10
5. J.M. Chan, L. Zhang, K.P. Yuet, G. Liao, J.-W. Rhee, R. Langer, and O.C. Farokhzad PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery Biomaterials 30 2009 1627 1634
6. P. Decuzzi, and M. Ferrari The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles Biomaterials 28 2007 2915 2922
7. C. Fang, B. Shi, Y.Y. Pei, M.H. Hong, J. Wu, and H.Z. Chen In vivo tumor targeting of tumor necrosis factor-a-loaded stealth nanoparticles: effect of MPEG molecular weight and particle size Eur. J. Pharm. Sci. 27 2006 27 36
8. O.C. Farokhzad, J. Cheng, B.A. Teply, I. Sherifi, S. Jon, P.W. Kantoff, J.P. Richie, and R. Langer Targeted nanoparticle-aptamer, bioconjugates for cancer chemotherapy in vivo Proc. Natl. Acad. Sci. U.S.A. 103 2006 6315 6320
9. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom Cremophor EL, the drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer 37 2001 1590 1598
10. E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-Pouessel, B. Denizot, P. Menei, and J.P. Benoit A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats Mol. Cancer Ther. 5 2006 1710 1722
11. A.M. Harmon, M.H. Lash, S.M. Sparks, and K.E. Uhrich Preferential cellular uptake of amphiphilic macromolecule-lipid complexes with enhanced stability and biocompatibility J. Controlled Release 153 2011 233 239
12. T. Hamaguchi, Y. Matsumura, M. Suzuki, R. Goda, I. Nakamura, I. Nakatomi, M. Yokoyama, K. Kataoka, and T. Kakizoe NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo anti-tumor activity and reduce the neurotoxicity of paclitaxel Br. J. Cancer 92 2005 1240 1246
13. Y. Liu, J. Pan, and S.S. Feng Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance Int. J. Pharm. 395 2010 243 250
14. Y.T. Liu, and S.S. Feng The synergistic effect of herceptin and docetaxel in polylactide-d-α-tocopheryl polyethylene glycol succinate (PLA-TPGS) nanoparticles J. Controlled Release 152 2011 64 65
15. J.H. Michael, S.S. Patrick, and D. Neil Protein nanoparticles as drug carrier in clinical medicine Adv. Drug Del. Rev. 60 2008 876 885
16. ®) J. Controlled Release 80 2002 129 144
17. ®): PLGA nanoparticles containing vitamin E TPGS J. Controlled Release 86 2003 33 48
18. L. Mu, and S.S. Feng PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and the drug loading ratio Pharm. Res. 20 2003 1864 1872
19. D.E. Owen III, and N.A. Peppas Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102
20. S.D. Perrault, C. Walkey, T. Jennings, and H.C. Fischer Chan WCW mediating tumor targeting efficiency of nanoparticles through design Nano Lett. 2009 1909 1915
21. N. Song, W. Liu, Q. Tu, R. Liu, and J. Wang Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery Colloids Surf. B 87 2011 454 463
22. C. Salvador-Morales, L. Zhang, R. Langer, and O.C. Farokhzad Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups Biomaterials 30 2009 2231 2240
23. M.J. Shieh, C.Y. Hsu, L.Y. Huang, H.Y. Chen, F.H. Huang, and P.S. Lai Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells J. Controlled Release 152 2011 418 425
24. Y.H. Tao, R. Liu, M.Q. Chen, C. Yang, and X.Y. Liu Cross-linked micelles of graftlike block copolymer bearing biodegradable epsilon-caprolactone branches: a novel delivery carrier for paclitaxel J. Mater. Chem. 22 2012 373 380
25. M. Takeda, I. Okamoto, N. Hirabayashi, M. Kitano, and K. Nakagawa Thymidylate, synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer Lung Cancer 73 2011 103 109
26. R.P. Tang, W.H. Ji, D. Panus, R.N. Palumbo, and C. Wang Block copolymer micelles with acid-labile ortho ester side-chains: synthesis, characterization, and enhanced drug delivery to human glioma cells J. Controlled Release 151 2011 18 27
27. J.F. Wang, W.M. Liu, Q. Tu, J.C. Wang, N. Song, Y.R. Zhang, N. Nie, and J.Y. Wang Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery Biomacromolecules 12 2011 228 234
28. K.Y. Wina, and S.S. Feng Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs Biomaterials 26 2005 2713 2722
29. K. Xiao, Y.P. Li, and J.S. Lee "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo Cancer Res. 72 2012 2100 2110
30. D.B. Yang, S. Van, X.G. Jiang, and L. Yu Novel free paclitaxel-loaded poly(l-γ-glutamylglutamine)-paclitaxel nanoparticles: I J. Nanomed. 6 2011 85 91
31. H.J. Yao, R.J. Ju, X.X. Wang, Y. Zhang, R.J. Li, Y. Yu, L. Zhang, and W.L. Lu The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery Biomaterials 32 2011 3285 3302
32. Y. Yun, J. Zou, L. Yu, W. Jo, Y.K. Li, W.C. Law, and C. Cheng Functional polylactide-g-paclitaxel-poly(ethylene glycol) by azide-alkyne click chemistry Macromolecules 44 2011 4793 4800
33. J. Zhao, C.S. Liu, Y. Yuan, X.Y. Tao, X.Q. Shan, and Y. Sheng Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers Biomaterials 28 2007 1414 1422
34. L.H. Zhang, Y.N. He, M. Yu, and C.X. Song Paclitaxel-loaded polymeric nanoparticles based on PCL-PEG-PCL: preparation, in vitro and in vivo evaluation J. Controlled Release 152 2011 114 116
35. L.F. Zhang, J.M. Chan, X. Frank, J.W. Rhee, A.Z. Wang, A.F. Radovic-Moreno, F. Alexis, R. Langer, and O.C. Farokhzad Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform J. Am. Chem. Soc. 08 2008 1696 1702
36. L. Zhang, and L. Zhang Lipid-polymer hybrid nanoparticles: synithesis, characterization and applications Nano LIFE 01 2010 163 173
37. Z.P. Zhang, S.W. Tan, and S.-S. Feng Vitamin E TPGS as a molecular biomaterial for drug delivery Biomaterials 33 2012 4889 4906
38. Y.T. Zhang, J.W. Hou, C.Y. Qian, L. Song, and S.R. Guo Taxol-loaded nanoparticles with methoxy poly(ethylene glycol)-b-poly(epsilon-caprolactone) as a novel additive in the outer aqueous phase J. Appl. Polym. Sci. 121 2011 2386 2393